Brief: CMS And Incyte Announce Collaboration And License Agreement For Povorcitinib In China And Southeast Asia
April 1 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* CMS AND INCYTE ANNOUNCE COLLABORATION AND LICENSE
AGREEMENT FOR
POVORCITINIB IN CHINA AND SOUTHEAST ASIA
* CHINA MEDICAL SYSTEM HOLDINGS: WILL MAKE UPFRONT PAYMENT
TO
INCYTE, INCYTE ELIGIBLE TO GET ADDITIONAL POTENTIAL DEVELOPMENT
AND COMMERCIAL MILESTONES
Source text for Eikon: ID:nGNX23HDQ3
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says